Alternate Donor Study of Pre-Emptive Cellular Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to evaluate the potential clinical benefit of pre-emptive cytomegalovirus (CMV)-specific adoptive cellular therapy following T cell depleted allogeneic hematopoietic stem cell transplantation (HSCT) for reducing recurrent CMV reactivation.
Epistemonikos ID: 76516dc59d73b59d69c49bdb92c965899dda52b4
First added on: May 06, 2024